Unknown

Dataset Information

0

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?

ABSTRACT:

SUBMITTER: Thornton C 

PROVIDER: S-EPMC7869784 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?

Thornton Christina C   Chin Melanie M   Somayaji Ranjani R  

Annals of the American Thoracic Society 20210201 2

Similar Datasets

Unknown Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.
| S-EPMC7869777 | biostudies-literature
Unknown Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.
| S-EPMC6600836 | biostudies-literature
Unknown Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis.
| S-EPMC7049934 | biostudies-literature
Unknown Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations.
| S-EPMC5472380 | biostudies-literature
Unknown The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison.
| S-EPMC4989998 | biostudies-literature
Unknown Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis.
| S-EPMC10879674 | biostudies-literature
Unknown Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
| S-EPMC9342853 | biostudies-literature
Unknown Role of hyperglycemia in cystic fibrosis pulmonary exacerbations.
| S-EPMC10756929 | biostudies-literature
Unknown Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.
| S-EPMC5672808 | biostudies-literature
Unknown Changing Epidemiology of Pediatric Pulmonary Exacerbations in Cystic Fibrosis.
| S-EPMC12043277 | biostudies-literature